TALDO1 is activated by nuclear factor erythroid-2-related factor 2 (NRF2) [52], a promoter of tumor progression, which inhibits EMT by suppressing snail expression during pulmonary fibrosis in mice experiments [53]. Here, NFE2L2 is linked to pulmonary fibrosis.